glp 1 agonist and dpp 4 inhibitor GLP-1 receptor agonists DPP-4 inhibitors Pathway, Pharmacodynamics Mechanism of action for GIP,
Description
353 i2231
Despite their promise, GLP-1 drugs need to be treated with caution
This likely reflects methodological characteristics inherent to in vitro research, where randomization and blinding are usually not applicable, rather than a true source of systematic bias
Luciani, P., Fibbi, B., Mazzanti, B., Deledda, C., Ballerini, L., Aldinucci, A., et al
242 , R491497 (1982)
